Bio-Rad Laboratories, Inc. (BIO)

Laboratory Analytical Instruments

Latest Price

$377.71

TTM P/E

46.12

Normalized P/E

Div Yield

Book Value

267.16

P/B Ratio

1.41

Valuation metrics

EPS: $27.85

Book value / share: $273.22

Formula: √(22.5 × EPS × BVPS)

Graham Number

$413.77

+10% upside

Norm. op. income: $338M (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$108.55

71% downside

Base FCF: $290M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$802.41

+112% upside

EPS: $27.85

Target P/E: 46×

Formula: EPS × P/E

P/E Fair Value

$1,281.10

+239% upside

87.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
First Eagle Investment Management, LLC	2.61M	$765.0M	12.01%	+3.4K	2026-06-30
BlackRock, Inc.	1.70M	$498.0M	7.83%	+18.9K	2026-06-30
Dimensional Fund Advisors LP	944.5K	$277.0M	4.35%	-144.8K	2026-06-30
Vanguard Capital Management LLC	827.0K	$242.0M	3.81%	-4.2K	2026-06-30
Ariel Investments, LLC	816.8K	$239.0M	3.76%	+30.8K	2026-06-30
Vanguard Portfolio Management LLC	816.2K	$239.0M	3.76%	-13.0K	2026-06-30
Earnest Partners LLC	580.8K	$170.0M	2.68%	-8.0K	2026-06-30
State Street Corp	571.8K	$167.0M	2.63%	+12.2K	2026-06-30
Bank of America Corp	490.4K	$143.0M	2.26%	+45.5K	2026-06-30
Capital World Investors	462.5K	$135.0M	2.13%	+12.5K	2026-06-30